Belgium's Omega Pharma May Sell Itself

Omega Pharma, a Belgian healthcare products distributor, is considering selling itself nearly three years after it was taken private by its founder, the news agency Bloomberg said, citing sources.

A sale of the Nazareth, Belgium-based company could earn its owners more than $4 billion, Bloomberg added.

Omega, which sells prescription-free medicines, healthcare products and over-the-counter items such as wart treatments and sun tan lotions, is believed to have hired investment bank Morgan Stanley to handle the sale, which could start as early as this month.

Founder and CEO Marc Coucke took the company private in 2011 with his $1.1 billion takeover offer for the maker of painkiller Solpadeine

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.